Zinger Key Points
- Snap shares dipped 12.91% following a report that Trump is considering an executive order to save TikTok from a U.S. ban.
- Moderna dropped 19.35% after issuing 2025 revenue guidance below analyst expectations
- Volatility can create massive trading opportunities—if you know how to capitalize on it. On Sunday, March 23, at 1 PM ET, Matt Maley is revealing the strategies behind his recent trades made in this volatile market, which have delivered gains up to 450%. Click to register for free.
These eleven large-cap stocks were the worst performers in the last week. Are they in your portfolio?
- FTAI Aviation Ltd. FTAI shares plummeted 35.42% after short seller firm Muddy Waters Research announced they initiated a short position in the company.
- Moderna, Inc. MRNA stock plunged 19.38% after the company updated its 2025 expected revenue range to $1.5 billion to $2.5 billion, below analyst estimates of $2.951 billion. Morgan Stanley maintained an Equal-Weight rating and lowered the price forecast from $70 to $38.
- GameStop Corporation GME stock declined 14.86%. In a recent X post, CNBC's Jim Cramer steered investors toward quantum stocks, suggesting they reinvest gains from GameStop into Rigetti Computing Inc RGTI.
- Snap Inc. SNAP shares dipped 12.91% following a report suggesting that Trump is considering an executive order to save TikTok from a U.S. ban.
- Rocket Lab USA, Inc. RKLB shares were down 10.81%. The company disclosed that its second Pioneer spacecraft for Varda Space Industries, Inc. is successfully operating in orbit.
- Natera, Inc. NTRA stock lost 9.51% last week despite Guggenheim raising the price forecast from $170 to $200. The company is due to provide a roadmap and outlook at the J.P. Morgan Healthcare Conference.
- Eli Lilly and Company LLY stock decreased 9.27% after the company issued FY24 revenue guidance below the previous estimate.
- ICON plc ICLR stock fell 9.22% after the company issued FY25 guidance with its midpoint below estimates.
- BioNTech SE BNTX shares declined 8.89% after Moderna issued 2025 revenue guidance below analyst estimates.
- Novo Nordisk A/S NVO shares fell 8.89% after Ozempic and Wegovy were included in a list of 15 medications for Medicare drug price negotiations.
- BioMarin Pharmaceutical Inc. BMRN shares tumbled 8.68%. The company initiated a legal action against Ascendis Pharma A/S for infringement of European patent EP 3 175 863 B1 at the Unified Patent Court (UPC) in Munich, Germany.
Photos courtesy: Shutterstock
GMEGameStop Corp
$25.056.55%
Edge Rankings
Momentum93.82
Growth5.82
Quality-
Value49.32
Price Trend
Short
Medium
Long
MRNAModerna Inc
$32.730.86%
SNAPSnap Inc
$9.351.30%
BMRNBiomarin Pharmaceutical Inc
$71.900.42%
BNTXBioNTech SE
$96.00-0.24%
FTAIFTAI Aviation Ltd
$107.110.38%
ICLRIcon PLC
$184.870.49%
LLYEli Lilly and Co
$841.99-0.07%
NTRANatera Inc
$151.151.02%
NVONovo Nordisk AS
$76.91-2.39%
RGTIRigetti Computing Inc
$9.020.33%
RKLBRocket Lab USA Inc
$18.942.21%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in